Literature DB >> 11587278

Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer.

S R Cole1, G P Young.   

Abstract

OBJECTIVES: To determine if participation in colorectal cancer screening using faecal occult blood testing (FOBT) is affected by a restrictive diet and if it is associated with certain demographic variables. PARTICIPANTS AND
SETTING: 1,203 residents of South Australia aged 50-69 years, with no "currently active bowel disease", randomly selected from a database of people willing to be contacted about unspecified health issues.
DESIGN: Randomised controlled trial: participants were offered screening by immunochemical FOBT by mail in 1998. Half were randomly allocated to a group instructed to follow a low-peroxidase diet, as required for guaiac FOBT, while the other group was not so restricted. MAIN OUTCOME MEASURES: Effect of diet restriction on participation (return of correctly completed FOBT sample cards within 15 weeks); time taken to return cards; relationships between participation and demographic variables.
RESULTS: Participation rates were 65.9% (no-diet group) and 53.3% (diet group) (difference, 12.6%; 95% CI, 7.1%-18.1%). In the first week, rates of return as a proportion of all tests returned were 13.1% (no-diet) and 1.6% (diet) (difference, 11.5%; 95% CI, 8.6%-14.4%), increasing to 54.3% and 44.5%, respectively, after five weeks (difference, 9.8%; 95% CI, 4.2%-15.4%). Participation was significantly associated with older age (odds ratio, 1.40; 95% CI, 1.10-1.78), but not sex, Index of Social Disadvantage or rural versus urban address.
CONCLUSIONS: Dietary restrictions create a barrier to FOBT-based screening for colorectal cancer. The use of immunochemical rather than guaiac FOBT removes this barrier.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587278     DOI: 10.5694/j.1326-5377.2001.tb143094.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

1.  Editorial for International Journal of Behavioral Medicine: special issue on cancer.

Authors:  Michael H Antoni
Journal:  Int J Behav Med       Date:  2011-12

Review 2.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

3.  Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.

Authors:  Grace Clarke Hillyer; Karen M Schmitt; Daniel E Freedberg; Rachel A Kramer; Yin Su; Richard M Rosenberg; Alfred I Neugut
Journal:  Am J Prev Med       Date:  2014-06-17       Impact factor: 5.043

4.  Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.

Authors:  K Allen Greiner; Christine M Daley; Aaron Epp; Aimee James; Hung-Wen Yeh; Mugur Geana; Wendi Born; Kimberly K Engelman; Jeremy Shellhorn; Christina M Hester; Joseph LeMaster; Daniel C Buckles; Edward F Ellerbeck
Journal:  Am J Prev Med       Date:  2014-11-18       Impact factor: 5.043

5.  Psychosocial variables associated with colorectal cancer screening in South Australia.

Authors:  Stephen R Cole; Ian Zajac; Tess Gregory; Sarah Mehaffey; Naomi Roosa; Deborah Turnbull; Adrian Esterman; Graeme P Young
Journal:  Int J Behav Med       Date:  2011-12

6.  Factors influencing colorectal cancer screening participation.

Authors:  Antonio Z Gimeno García
Journal:  Gastroenterol Res Pract       Date:  2011-12-01       Impact factor: 2.260

7.  Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Authors:  L Sharp; L Tilson; S Whyte; A O'Ceilleachair; C Walsh; C Usher; P Tappenden; J Chilcott; A Staines; M Barry; H Comber
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640

8.  Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.

Authors:  Daiga Santare; Ilona Kojalo; Teppo Huttunen; Sergejs Rikacovs; Peteris Rucevskis; Viesturs Boka; Marcis Leja
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-05       Impact factor: 2.566

Review 9.  Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).

Authors:  James E Allison; Callum G Fraser; Stephen P Halloran; Graeme P Young
Journal:  Gut Liver       Date:  2014-03-11       Impact factor: 4.519

Review 10.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.